Filing Details
- Accession Number:
- 0000769993-20-000239
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-05-19 12:06:39
- Reporting Period:
- 2020-04-01
- Accepted Time:
- 2020-05-19 12:06:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1000229 | Core Laboratories N V | CLB | () | NY |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 769993 | Goldman Sachs & Co. Llc | 200 West Street New York NY 10282 | No | No | No | No | |
| 886982 | Goldman Sachs Group Inc | 200 West Street New York NY 10282 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Acquisiton | 2020-04-01 | 376 | $9.41 | 4,640,600 | No | 4 | P | Indirect | Through Subsidiary |
| Common Shares | Acquisiton | 2020-04-01 | 300 | $9.25 | 4,640,900 | No | 4 | P | Indirect | Through Subsidiary |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | Through Subsidiary |
| No | 4 | P | Indirect | Through Subsidiary |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Shares | Equity Swap | Disposition | 2020-04-01 | 1,176 | $0.00 | 1,176 | $0.00 |
| Common Shares | Equity Swap | Acquisiton | 2020-04-01 | 93 | $0.00 | 93 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 1,176 | 2023-11-15 | No | 4 | S | Indirect | |
| 93 | 2029-08-13 | No | 4 | P | Indirect |
Footnotes
- The amount of profit recoverable by the Issuer from the reported transactions will be remitted to the Issuer.
- This statement is being filed by The Goldman Sachs Group, Inc. ("GS Group") and Goldman Sachs & Co. LLC. ("Goldman Sachs" and, together with GS Group, the "Reporting Persons". Goldman Sachs is a wholly-owned subsidiary of GS Group. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein. On April 1, 2020, the Reporting Persons ceased to be a greater than 10% beneficial owner of the Issuer's Common Shares but did not experience a change in their pecuniary interest in the Issuer.
- GS Group may be deemed to beneficially own indirectly the Common Shares by reason of Goldman Sachs' direct beneficial ownership.
- Goldman Sachs entered into an equity swap agreement which, upon the termination of the agreement on 11/15/2023, Goldman Sachs will pay to the counterparty any increase in the price of the Common Shares above $9.29 per share and the counterparty will pay to Goldman Sachs any decrease in the price of the Common Shares below $9.29 per share, in each case, based on a notional amount of 1,176 Common Shares and any additional costs and charges including any payments with respect to financial dividends.
- Goldman Sachs entered into an equity swap agreement which, upon the termination of the agreement on 8/13/2029, Goldman Sachs will pay to the counterparty any decrease in the price of the Common Shares below $9.45 per share and the counterparty will pay Goldman Sachs any increase in the price of the Common Shares above $9.45 per share, in each case, based on a notional amount of 93 Common Shares and any additional costs and charges including any payments with respect to financial dividends.
Billionaire Hedge Funds
